Bristol Meyer ties up with AI pharmatech Exscientia
Bristol-Myers Squibb, the Big Pharma company, has entered into a drug discovery collaboration worth $1.2 billion, with artificial intelligence (AI) pharmatech company, Exscientia.
Bristol-Myers Squibb, the Big Pharma company, has entered into a drug discovery collaboration worth $1.2 billion, with artificial intelligence (AI) pharmatech company, Exscientia.